Leukotriene B4 at low dosage negates the catabolic effect of prostaglandin E2 in human patellar tendon fibroblasts

Gene

Volumn 372, Issue 1-2, 2006, Pages 103-109

  Thampatty, Bhavani P ^a   Im, Hee Jeong ^b   Wang, James H C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Collagen; LTB4; MMPs; PGE2; Tendon fibroblasts

Indexed keywords

COLLAGEN TYPE 1; INTERSTITIAL COLLAGENASE; LEUKOTRIENE B4; MESSENGER RNA; PROSTAGLANDIN E2; COLLAGEN; STROMELYSIN;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; PATELLA TENDON; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TENDON DISEASE; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATELLA; TENDON;

CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LEUKOTRIENE B4; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; PATELLA; RNA, MESSENGER; TENDONS;

EID: 33745268445     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2005.12.013     Document Type: Article

References (45)

1. Almekinders L.C. Tendinitis and other chronic tendinopathies. J. Am. Acad. Orthop. Surg. 6 (1998) 157-164
2. Almekinders L.C., Banes A.J., and Ballenger C.A. Effects of repetitive motion on human fibroblasts. Med. Sci. Sports Exerc. 25 (1993) 603-607
3. Almekinders L.C., Baynes A.J., and Bracey L.W. An in vitro investigation into the effects of repetitive motion and nonsteroidal antiinflammatory medication on human tendon fibroblasts. Am. J. Sports Med. 23 (1995) 119-123
4. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J. Periodontol. 64 (1993) 474-484
5. Birkedal-Hansen H., et al. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4 (1993) 197-250
6. Brach M.A., de Vos S., Arnold C., Gruss H.J., Mertelsmann R., and Herrmann F. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-chi B and NF-IL6. Eur. J. Immunol. 22 (1992) 2705-2711
7. Cilli F., Khan M., Fu F., and Wang J.H. Prostaglandin E2 affects proliferation and collagen synthesis by human patellar tendon fibroblasts. Clin. J. Sport Med. 14 (2004) 232-236
8. Davidson E.M., Rae S.A., and Smith M.J. Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis. Ann. Rheum. Dis. 42 (1983) 677-679
9. Denzlinger C. Biology and pathophysiology of leukotrienes. Crit. Rev. Oncol. Hematol. 23 (1996) 167-223
10. Domeij H., Yucel-Lindberg T., and Modeer T. Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur. J. Oral Sci. 110 (2002) 302-306
11. Fingleton B., and Matrisian L.M. Matrix metalloproteinases as targets for therapy in Kaposi sarcoma. Curr. Opin. Oncol. 13 (2001) 368-373
12. Henderson Jr. W.R. The role of leukotrienes in inflammation. Ann. Intern. Med. 121 (1994) 684-697
13. Konstan M.W., Walenga R.W., Hilliard K.A., and Hilliard J.B. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis. Am. Rev. Respir. Dis. 148 (1993) 896-901
14. Kragballe K., Desjarlais L., and Voorhees J.J. Leukotrienes B4, C4 and D4 stimulate DNA synthesis in cultured human epidermal keratinocytes. Br. J. Dermatol. 113 (1985) 43-52
15. Langberg H., Skovgaard D., Karamouzis M., Bulow J., and Kjaer M. Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. J. Physiol. 515 Pt 3 (1999) 919-927
16. Lawrence T., Willoughby D.A., and Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2 (2002) 787-795
17. Li Z., Yang G., Khan M., Stone D., Woo S.L., and Wang J.H. Inflammatory response of human tendon fibroblasts to cyclic mechanical stretching. Am. J. Sports Med. 32 (2004) 435-440
18. Maffulli N., Khan K.M., and Puddu G. Overuse tendon conditions: time to change a confusing terminology. Arthroscopy 14 (1998) 840-843
19. Malich G., Markovic B., and Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology 124 (1997) 179-192
20. Mattern M.R., et al. Transient activation of topoisomerase I in leukotriene D4 signal transduction in human cells. Biochem. J. 265 (1990) 101-107
21. Moreland D.B., Soloniuk D.S., and Feldman M.J. Leukotrienes in experimental spinal cord injury. Surg. Neurol. 31 (1989) 277-280
22. Murphy G., Cockett M.I., Stephens P.E., Smith B.J., and Docherty A.J. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem. J. 248 (1987) 265-268
23. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79 (1999) 1193-1226
24. Negishi M., Sugimoto Y., and Ichikawa A. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta 1259 (1995) 109-119
25. Palmberg L., Claesson H.E., and Thyberg J. Leukotrienes stimulate initiation of DNA synthesis in cultured arterial smooth muscle cells. J. Cell Sci. 88 Pt 2 (1987) 151-159
26. Palmberg L., Claesson H.E., and Thyberg J. Effects of leukotrienes on phenotypic properties and growth of arterial smooth muscle cells in primary culture. J. Cell Sci. 93 Pt 3 (1989) 403-408
27. Pardo A., and Selman M. MMP-1: the elder of the family. Int. J. Biochem. Cell Biol. 37 (2005) 283-288
28. Phan S.H., McGarry B.M., Loeffler K.M., and Kunkel S.L. Regulation of macrophage-derived fibroblast growth factor release by arachidonate metabolites. J. Leukoc. Biol. 42 (1987) 106-113
29. Phan S.H., McGarry B.M., Loeffler K.M., and Kunkel S.L. Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro. Biochemistry 27 (1988) 2846-2853
30. Quinn J.H., and Bazan N.G. Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful, dysfunctional temporomandibular joints. J. Oral Maxillofac. Surg. 48 (1990) 968-971
31. Riley G. Chronic tendon pathology: molecular basis and therapeutic implications. Expert Rev. Mol. Med. 7 (2005) 1-25
32. Riley G.P. Gene expression and matrix turnover in overused and damaged tendons. Scand. J. Med. Sci. Sports 15 (2005) 241-251
33. Riquet F.B., Lai W.F., Birkhead J.R., Suen L.F., Karsenty G., and Goldring M.B. Suppression of type I collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Mol. Med. 6 (2000) 705-719
34. Rola-Pleszczynski M., and Stankova J. Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood 80 (1992) 1004-1011
35. Sakaki H., et al. Interleukin-1beta induces matrix metalloproteinase-1 expression in cultured human gingival fibroblasts: role of cyclooxygenase-2 and prostaglandin E2. Oral Dis. 10 (2004) 87-93
36. Serhan C.N., and Levy B. Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8609-8611
37. Sharon P., and Stenson W.F. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 86 (1984) 453-460
38. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
39. Tager A.M., and Luster A.D. BLT1 and BLT2: the leukotriene B(4) receptors. Prostaglandins Leukot. Essent. Fat. Acids 69 (2003) 123-134
40. Trebino C.E., et al. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9044-9049
41. Tsuzaki M., et al. IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells. J. Orthop. Res. 21 (2003) 256-264
42. Varga J., Diaz-Perez A., Rosenbloom J., and Jimenez S.A. PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts. Biochem. Biophys. Res. Commun. 147 (1987) 1282-1288
43. Visse R., and Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92 (2003) 827-839
44. Wang J.H. Mechanobiology of tendon. J. Biomech. (2005)
45. Wang J.H., et al. Cyclic mechanical stretching of human tendon fibroblasts increases the production of prostaglandin E2 and levels of cyclooxygenase expression: a novel in vitro model study. Connect Tissue Res. 44 (2003) 128-133